NasdaqGS:NVAXBiotechs
Are Novavax's (NVAX) Diverging Quarterly and Half-Year Results a Sign of Shifting Momentum?
On August 6, 2025, Novavax reported second quarter earnings, with revenue of US$239.24 million and net income of US$106.51 million, both down compared to the same quarter last year, but first-half revenue and net income rose sharply year-over-year.
The contrasting quarterly and half-year results highlight the company's ability to deliver substantial gains over six months despite short-term variability.
We'll explore how Novavax's year-to-date financial improvement affects its investment...